# PROPANC BIOPHARMA INC (PPCB)

> Institutional ownership reported to the SEC as of Q1 2026, from Form 13F filings. Source: https://holderbook.com/stocks/PPCB/

- Reporting holders: 6
- Reported value: $48.7K
- Shares held by institutions: 462,396 of 15,859,280 outstanding
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [UBS Group AG](https://holderbook.com/funds/1610520-ubs-group-ag/) | $19.4K | 182,614 | 0.0% | 1 |
| [JANE STREET GROUP, LLC](https://holderbook.com/funds/1595888-jane-street-group-llc/) | $15.2K | 143,212 | 0.0% | 1 |
| [Marex Group plc](https://holderbook.com/funds/1997464-marex-group-plc/) | $7.2K | 67,724 | 0.0% | 3 |
| [Virtu Financial LLC](https://holderbook.com/funds/1533964-virtu-financial-llc/) | $4.0K | 40,748 | 0.0% | 1 |
| [Sassicaia Capital Advisers LLC](https://holderbook.com/funds/1692751-sassicaia-capital-advisers-llc/) | $1.7K | 16,000 | 0.0% | 1 |
| [XTX Topco Ltd](https://holderbook.com/funds/1828301-xtx-topco-ltd/) | $1.3K | 12,098 | 0.0% | 2 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q1 2026 | 6 | $48.7K |
| Q4 2025 | 5 | $69.5K |
| Q3 2025 | 3 | $190.7K |
| Q3 2021 | 1 | $1.0K |
| Q2 2021 | 1 | $1.0K |
| Q1 2021 | 1 | $5.0K |